PD-L1 and PD-L2 is highly expressed in Epstein-Barr virus (EBV)-positive lymphomas, including DLBCL, extranodal NK/T-cell lymphoma, aggressive NK cell leukemia and T-cell lymphoproliferative diseases (38). Here, PDCD1LG2 is linked to diffuse large B-cell lymphoma.